Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006399
Filing Date
2024-11-12
Accepted
2024-11-12 09:31:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 MOLECULAR TEMPLATES, INC. p24-3034sc13ga.htm SC 13G/A 68674
  Complete submission text file 0000902664-24-006399.txt   70362
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Subject) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81377 | Film No.: 241444195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A